The Ebstein anomaly and the difficulty in drawing conclusions for decision-making
Results from the experience of six centers in Australia and New Zealand in the management of Ebstein anomaly over 34 years.
Valvulopathies
On-X® Aortic Prosthesis Carriers in Aortic Position: Is This the End of Anticoagulation Demonization?
This study confirms the findings of the PROACT trial on the safety profile of reducing oral anticoagulation in patients with an On-X® prosthetic valve in the aortic position.
What does closing the left atrial appendage during mitral repair offer in patients without atrial fibrillation?
This single-center, retrospective study compares the utility of left atrial appendage (LAA) closure in patients undergoing mitral valve repair without atrial fibrillation (AF).
Inspiris Resilia in pulmonary position: a warning
A retrospective single-center study comparing outcomes of the Inspiris Resilia bioprostheses versus Mosaic.
The Dark Side of TAVI: Results from the International Explant Registry
Periprocedural and one-year mortality and perioperative outcomes from TAVI device explants across various etiologies, as recorded in the EXPANT-TAVR international registry.
Aortic Valve Replacement with Carpentier Edwards Magna Ease® Bioprosthesis: A Decade of Follow-Up
This article retrospectively analyzes clinical and hemodynamic outcomes in 689 adults who underwent surgical aortic valve replacement with the Carpentier Edwards Magna Ease® bioprosthesis over a ten-year follow-up.
Commando procedure in non-endocarditis contexts: the Cleveland Clinic experience
This retrospective analysis spans ten years of single-center interventions, evaluating the Commando procedure in non-infectious mitral-aortic involvement cases.
Should We Repair Mild or Moderate Tricuspid Regurgitation During Degenerative Mitral Surgery?
A retrospective study at Mayo Clinic analyzed outcomes of mild or moderate tricuspid repair among 1,588 patients with degenerative mitral valve disease.
Sutureless Perceval® Valve Procedures: Thirteen-Year Experience in 784 Patients
This retrospective analysis examines both short- and long-term outcomes (spanning thirteen years) of patients treated with Perceval® sutureless valves at a single Belgian center.
Summer Hits: DEDICATE Trial, TAVI’s New Success Story in Low-Risk Patients
In-depth analysis of the German multicenter DEDICATE study presents one-year outcomes in low-surgical-risk TAVI patients compared to aortic valve replacement, allowing the inclusion of patients younger than 75 years.